Energain (Korea Genetic Pharm Co., Ltd)


Welcome to the PulseAid listing for the Energain drug offered from Korea Genetic Pharm Co., Ltd. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Korea Genetic Pharm Co., Ltd
NON-PROPRIETARY NAME: TRIBULUS TERRESTRIS ROOT
SUBSTANCE NAME: TRIBULUS TERRESTRIS ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: GRANULE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-02-07
END MARKETING DATE: 0000-00-00


Energain HUMAN OTC DRUG Details:

Item DescriptionEnergain from Korea Genetic Pharm Co., Ltd
LABELER NAME: Korea Genetic Pharm Co., Ltd
DEA SCHEDULE:
ACTIVE STRENGTH: 8(g/100g)
START MARKETING DATE: 2012-02-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42707-2001_31876fea-b452-41c1-8723-2db49e9cee82
PRODUCT NDC: 42707-2001
APPLICATION NUMBER:

Other TRIBULUS TERRESTRIS ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Korea Genetic Pharm Co., LtdEnergain